Related Experiment Video
Updated: Jun 19, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Left ventricular non-compaction as a potential source for cryptogenic ischemic stroke in the young: A case-control
Pauli Pöyhönen1, Jouni Kuusisto1, Vesa Järvinen2
1Heart and Lung Center, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
Insights
Left ventricular non-compaction is linked to increased risk of cryptogenic ischemic stroke in young adults. This finding holds true even without patent foramen ovale or cardiomyopathy, suggesting a novel stroke etiology.
Area of Science:
- Cardiology
- Neurology
- Medical Imaging
Background:
- Cryptogenic ischemic strokes affect up to 50% of young adults.
- Patent foramen ovale (PFO) is a common but low-risk source of embolism.
- Left ventricular (LV) non-compaction may cause stroke due to sluggish blood flow.
Purpose of the Study:
- Investigate LV non-compaction as a source of cryptogenic stroke in young adults.
- Assess the association between LV non-compaction and stroke etiology.
- Determine if LV non-compaction is an independent risk factor for stroke.
Main Methods:
- Prospective, multicenter case-control study (SECRETO; NCT01934725).
- 30 young stroke cases (18-49 years) and 30 controls underwent cardiac magnetic resonance (CMR).
- Transcranial Doppler (TCD) bubble test evaluated right-to-left shunt (RLS).
Main Results:
- No significant differences in LV volumes, mass, or systolic function between groups.
- LV non-compaction (mass and volume) was significantly higher in stroke cases.
- Increased LV non-compaction and RLS were independently associated with cryptogenic stroke.
Conclusions:
- LV non-compaction is a significant risk factor for cryptogenic ischemic stroke in young adults.
- This association is independent of RLS and the absence of cardiomyopathy.
- LV non-compaction represents a potential embolic source in young stroke patients.
Background:
Up to 50% of ischemic strokes in the young after thorough diagnostic work-up remain cryptogenic or associated with low-risk sources of cardioembolism such as patent foramen ovale (PFO). We studied with cardiac magnetic resonance (CMR) imaging, whether left ventricular (LV) non-compaction-a possible source for embolic stroke due to sluggish blood flow in deep intertrabecular recesses-is associated with cryptogenic strokes in the young.
Methods:
Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO; NCT01934725) is an international prospective multicenter case-control study of young adults (aged 18-49 years) presenting with an imaging-positive first-ever ischemic stroke of undetermined etiology. In this pilot substudy, 30 cases and 30 age- and sex-matched stroke-free controls were examined with CMR. Transcranial Doppler (TCD) bubble test was performed to evaluate the presence and magnitude of right-to-left shunt (RLS).
Results:
There were no significant differences in LV volumes, masses or systolic function between cases and controls; none of the participants had non-compaction cardiomyopathy. Semi-automated assessment of LV non-compaction was highly reproducible. Non-compacted LV mass (median 14.0 [interquartile range 12.6-16.0] g/m2 vs. 12.7 [10.4-16.6] g/m2, p = 0.045), the ratio of non-compacted to compacted LV mass (mean 25.6 ± 4.2% vs. 22.8 ± 6.0%, p = 0.015) and the percentage of non-compacted LV volume (mean 17.6 ± 2.9% vs. 15.7 ± 3.8%, p = 0.004) were higher in cases compared to controls. In a multivariate conditional logistic regression model including non-compacted LV volume, RLS and body mass index, the percentage of non-compacted LV volume (odds ratio [OR] 1.55, 95% confidence interval [CI] 1.10-2.18, p = 0.011) and the presence of RLS (OR 11.94, 95% CI 1.14-124.94, p = 0.038) were independently associated with cryptogenic ischemic stroke.
Conclusions:
LV non-compaction is associated with a heightened risk of cryptogenic ischemic stroke in young adults, independent of concomitant RLS and in the absence of cardiomyopathy.
Clinical Trial Registration:
SECRETO; NCT01934725. Registered 4th September 2013. https://clinicaltrials.gov/ct2/show/NCT01934725.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

